Evidence map›Paper›PMID 30580808›Full record

ArticleAmerican journal of human genetics2019

Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.

Keren Machol, Justine Rousseau, Sophie Ehresmann, Thomas Garcia, Thi Tuyet Mai Nguyen, Rebecca C Spillmann, Jennifer A Sullivan, Vandana Shashi, Yong-Hui Jiang, Nicholas Stong and 36 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genomic landscape of autism spectrum disorder in Brazil.Genetics and molecular biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Disrupted diencephalon development and neuropeptidergic pathways in zebrafish with autism-risk mutations.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 19 institutions in 7 countries.

Keren MacholDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Justine RousseauDepartment of Pediatrics, CHU Sainte-Justine Research Center and University of Montreal, Montreal, QC H3T 1C5, Canada.
Sophie EhresmannDepartment of Pediatrics, CHU Sainte-Justine Research Center and University of Montreal, Montreal, QC H3T 1C5, Canada.
Thomas GarciaDepartment of Pediatrics, CHU Sainte-Justine Research Center and University of Montreal, Montreal, QC H3T 1C5, Canada.
Thi Tuyet Mai NguyenDepartment of Pediatrics, CHU Sainte-Justine Research Center and University of Montreal, Montreal, QC H3T 1C5, Canada.
Rebecca C SpillmannDepartment of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.
Jennifer A SullivanDepartment of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.
Vandana ShashiDepartment of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.
Yong-Hui JiangDepartment of Pediatrics and Neurobiology, Program in Genetics and Genomics, Duke University School of Medicine, Durham, NC 27710, USA.
Nicholas StongInstitute for Genomic Medicine, Columbia University, New York, NY 10032, USA.
Elise FialaDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Marcia WillingDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Rolph PfundtHuman Genetics Department, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Tjitske KleefstraHuman Genetics Department, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Megan T ChoGeneDx, Gaithersburg, MD 20877, USA.
Heather McLaughlinGeneDx, Gaithersburg, MD 20877, USA.
Monica Rosello PieraUnidad de Genética, Hospital Universitario i Politècnic La Fe, 106, 46026 Valencia, Spain.
Carmen OrellanaUnidad de Genética, Hospital Universitario i Politècnic La Fe, 106, 46026 Valencia, Spain.
Francisco MartínezUnidad de Genética, Hospital Universitario i Politècnic La Fe, 106, 46026 Valencia, Spain.
Alfonso Caro-LlopisUnidad de Genética, Hospital Universitario i Politècnic La Fe, 106, 46026 Valencia, Spain.
Sandra MonfortUnidad de Genética, Hospital Universitario i Politècnic La Fe, 106, 46026 Valencia, Spain.
Tony RoscioliNeuroscience Research Australia (NeuRA), University of New South Wales, Sydney, NSW 2031, Australia; New South Wales Health Pathology, Randwick, NSW 2217, Australia; Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, NSW 2031, Australia.
Cheng Yee NixonNeuroscience Research Australia (NeuRA), University of New South Wales, Sydney, NSW 2031, Australia.
Michael F BuckleyNew South Wales Health Pathology, Randwick, NSW 2217, Australia.
Anne TurnerCentre for Clinical Genetics, Sydney Children's Hospital, Sydney, NSW 2031, Australia.
Wendy D JonesNorth East Thames Regional Genetics service, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Peter M van HasseltDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center, 3584 EA Utrecht, the Netherlands.
Floris C HofstedeDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center, 3584 EA Utrecht, the Netherlands.
Koen L I van GassenDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center, 3584 EA Utrecht, the Netherlands.
Alice S BrooksDepartment of Clinical Genetics, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands.
Marjon A van SlegtenhorstDepartment of Clinical Genetics, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands.
Katherine LachlanWessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton SO16 5YA, UK; Human Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Jessica SebastianDepartment of Medical Genetics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA.
Suneeta Madan-KhetarpalDepartment of Medical Genetics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA.
Desai SonalDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Naidu SakkubaiDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Julien ThevenonCentre de Génétique, Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est et FHU TRANSLAD, CHU Dijon, 21079 Dijon, France.
Laurence FaivreCentre de Génétique, Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est et FHU TRANSLAD, CHU Dijon, 21079 Dijon, France.
Alice MaurelCentre de Génétique, Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est et FHU TRANSLAD, CHU Dijon, 21079 Dijon, France.
Slavé PetrovskiAstraZeneca Centre for Genomics Research, Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge CB2 0AA, UK.
Ian D KrantzDepartment of Pediatrics and Division of Human Genetics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA 19104, USA.
Jennifer M TarpinianDepartment of Pediatrics and Division of Human Genetics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA 19104, USA.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Brendan H LeeDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Undiagnosed Diseases Network
Philippe M CampeauDepartment of Pediatrics, CHU Sainte-Justine Research Center and University of Montreal, Montreal, QC H3T 1C5, Canada. Electronic address: p.campeau@umontreal.ca.
Duke University · USCentre Hospitalier Universitaire Sainte-Justine · CABaylor College of Medicine · USCHU Dijon Bourgogne · FRHospital Universitari i Politècnic La Fe · ESColumbia University · USUNSW Sydney · AUWilhelmina Children's Hospital · NLChildren's Hospital of Philadelphia · USChildren's Hospital of Pittsburgh · USErasmus MC · NLGreat Ormond Street Hospital for Children NHS Foundation Trust · GBKennedy Krieger Institute · USNew South Wales Department of Health · AURadboud University Nijmegen · NLWashington University in St. Louis · USAstraZeneca (United Kingdom) · GBSydney Children's Hospital · AUUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

An integrated and diverse genomic medicine program for undiagnosed diseasesU01HG007672 · NHGRI · DUKE UNIVERSITY · PI SHASHI, VANDANA · 2014 to 2022
$13.4M
Clinical Sequencing Core Facility for the Undiagnosed Diseases Network (UDN)U01HG007942 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI ENG, CHRISTINE · 2014 to 2021
$10.2M
CIHRNHGRI NIH HHS U01 HG007672NHGRI NIH HHS U01 HG007942
6 · The paper itself

Abstract

SMARCC2 (BAF170) is one of the invariable core subunits of the ATP-dependent chromatin remodeling BAF (BRG1-associated factor) complex and plays a crucial role in embryogenesis and corticogenesis. Pathogenic variants in genes encoding other components of the BAF complex have been associated with intellectual disability syndromes. Despite its significant biological role, variants in SMARCC2 have not been directly associated with human disease previously. Using whole-exome sequencing and a web-based gene-matching program, we identified 15 individuals with variable degrees of neurodevelopmental delay and growth retardation harboring one of 13 heterozygous variants in SMARCC2, most of them novel and proven de novo. The clinical presentation overlaps with intellectual disability syndromes associated with other BAF subunits, such as Coffin-Siris and Nicolaides-Baraitser syndromes and includes prominent speech impairment, hypotonia, feeding difficulties, behavioral abnormalities, and dysmorphic features such as hypertrichosis, thick eyebrows, thin upper lip vermilion, and upturned nose. Nine out of the fifteen individuals harbor variants in the highly conserved SMARCC2 DNA-interacting domains (SANT and SWIRM) and present with a more severe phenotype. Two of these individuals present cardiac abnormalities. Transcriptomic analysis of fibroblasts from affected individuals highlights a group of differentially expressed genes with possible roles in regulation of neuronal development and function, namely H19, SCRG1, RELN, and CACNB4. Our findings suggest a novel SMARCC2-related syndrome that overlaps with neurodevelopmental disorders associated with variants in BAF-complex subunits.

Indexed as

MutationAbnormalities, MultipleAdolescentChildChild, PreschoolDevelopmental DisabilitiesDNA-Binding ProteinsFaceFemaleHand Deformities, CongenitalHumansIntellectual DisabilityMaleMicrognathismNeckReelin ProteinDNA-Binding ProteinsReelin ProteinRELN protein, humanSMARCC2 protein, humanTranscription FactorsBafopathydevelopmental delaydysmorphismsgenotype-phenotype correlationintellectual disabilityneurodevelopmental disorderspeech delaytranscriptome

Identifiers

PMID30580808
PMCPMC6323608
OpenAlexW2905799560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.